In another study, Li et al. demonstrated the ability of apigenin nanoparticles to reduce renal damage associated with diabetic kidney disease through activation of Nrf2/HO-1 and inhibition of the NF-κB signaling pathway [188] (Figure 3). The gene discussed is NFKB1; the disease is diabetic kidney disease.